Dopamine transporter silencing in the rat: systems-level alterations in striato-cerebellar and prefrontal-midbrain circuits

Silencing of dopamine transporter (DAT), a main controlling factor of dopaminergic signaling, results in biochemical and behavioral features characteristic for neuropsychiatric diseases with presumed hyperdopaminergia including schizophrenia, attention deficit hyperactivity disorder (ADHD), bipolar...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinwald, Jonathan R., Gass, Natalia, Mallien, Anne S., Sartorius, Alexander, Becker, Robert, Sack, Markus, Falfan-Melgoza, Claudia, Clemm von Hohenberg, Christian, Leo, Damiana, Pfeiffer, Natascha, Middelman, Anthonieke, Meyer-Lindenberg, Andreas, Homberg, Judith R., Weber-Fahr, Wolfgang, Gass, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126810/
https://www.ncbi.nlm.nih.gov/pubmed/35246636
http://dx.doi.org/10.1038/s41380-022-01471-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126810/
https://www.ncbi.nlm.nih.gov/pubmed/35246636
http://dx.doi.org/10.1038/s41380-022-01471-4

Ejemplares similares